{
  "id": 12167029,
  "title": "UBS reiterates Neutral rating on Coca-Cola Europacific Partners stock",
  "url": "https://urgent.news/2026/10/05/ubs-reiterates-neutral-rating-on-coca-cola-europacific-partners-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-05T14:22:44.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/ubs-reiterates-neutral-rating-on-cocacola-europacific-partners-stock-93CH-4932464"
  },
  "original_language": "en",
  "account": "Investing.com reports that UBS has maintained a Neutral rating on Coca-Cola Europacific Partners (CCEP) stock, with a price target of $107.00. Currently trading at $100.50, the stock sits marginally above UBS's Fair Value estimate, making it a subject of their \"most overvalued watchlist.\" The firm projects third-quarter organic sales growth of 5.4%, exceeding consensus estimates of 4.4%. UBS anticipates continued momentum in sales volume across Europe and the Asia Pacific region. Favorable weather conditions significantly boosted European consumer data for carbonated soft drinks, particularly through mid-September. In the Asia Pacific, UBS forecasts strong growth, primarily fueled by Indonesia and the Philippines, while Australia is expected to contribute to growth as it recovers from its previous Suntory partnership exit. UBS suggests the possibility of the company raising its full-year organic revenue guidance to as high as the 3% to 4% range. The company is expected to maintain its roughly 7% organic operating income guidance for the full year. According to UBS, CCEP is trading at a low P/E relative to near-term earnings growth, with a PEG ratio of 0.60. Recognized as one of over 1,400 US equities featured in comprehensive Pro Research Reports, CCEP transforms complex data into actionable intelligence. Notably, Coca-Cola Europacific Partners recently disclosed strong financial results for the first half of 2026. The company reported revenue of EUR 10.7 billion, representing a 6.1% growth on a comparable, foreign exchange-neutral basis. Diluted earnings per share also increased by 10.6% to €2.20. Despite these positive outcomes, the market showed a cautious response to the company's outlook for the remainder of the year. Analysts have begun to provide diverse opinions on the company's future performance. UBS downgraded CCEP from a Buy to Neutral, citing a 19% year-to-date rally in share price and a valuation premium compared to European staples. Conversely, Bernstein SocGen Group raised its price target for the company from $102 to $106, retaining a Market Perform rating due to the company's solid first-half results. These updates underscore the varied analyst perspectives on Coca-Cola Europacific Partners' future performance. This report was AI-assisted and reviewed by an editor.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}